Moneycontrol PRO
HomeNewsBusinessIPOEntero Healthcare Solutions IPO sees muted response even on second day of bidding

Entero Healthcare Solutions IPO sees muted response even on second day of bidding

The Faridabad-based healthcare products distributor intends to raise Rs 1,000 crore through fresh issue and the remaining Rs 600 crore via offer-for-sale (OFS) route. The price band for the offer is Rs 1,195-1,258 per share.

February 12, 2024 / 17:43 IST
Entero Healthcare Solutions IPO closes on February 13.
     
     
    26 Aug, 2025 12:21
    Volume
    Todays L/H
    More

    The Entero Healthcare Solutions IPO continued to see muted response even on the second day of bidding, February 12. Investors picked 13.85 lakh equity shares, which is 19 percent of the offer size of 71.5 lakh equity shares, as per the subscription data available with the exchanges.

    Retail investors and employees remained at the forefront to support the issue, buying 88 percent and 77 percent of the portions set aside for them, respectively, while non-institutional investors (high networth individuals) bid 9 percent shares of the allotted quota.

    Qualified institutional buyers have picked 825 equity shares against the reserved portion of 38.08 lakh shares.

    The Rs 1,600-crore public issue was subscribed 10 percent on its first day of bidding, i.e. February 9.

    The Faridabad-based healthcare products distributor intends to raise Rs 1,000 crore through fresh issue and the remaining Rs 600 crore via offer-for-sale (OFS) route. The price band for the offer is Rs 1,195-1,258 per share.

    Also read: Apeejay Surrendra Park Hotels lists with 20% premium over IPO price: Here's what analysts say

    There are several selling shareholders in the OFS including promoters OrbiMed Asia III Mauritius, Prabhat Agrawal, and Prem Sethi.

    US-based investment firm OrbiMed-backed OrbiMed Asia III Mauritius is the largest shareholder with 57.27 percent stake in the company, while total promoters shareholding stands at 77.11 percent.

    Entero Healthcare Solutions is going to utilise Rs 142.5 crore of the fresh issue proceeds for repaying debts, and Rs 480 crore for long term working capital requirements. And the balance fresh issue money will be kept aside for inorganic growth initiatives through acquisitions, and general corporate purposes.

    Also read: Akums Drugs files draft IPO papers with Sebi; eyes Rs 680 cr via fresh issue

    The public issue closes on February 13.

    Moneycontrol News
    first published: Feb 12, 2024 03:33 pm

    Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

    Subscribe to Tech Newsletters

    • On Saturdays

      Find the best of Al News in one place, specially curated for you every weekend.

    • Daily-Weekdays

      Stay on top of the latest tech trends and biggest startup news.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347